At the same time, loss of NF1, TSC1, or TβRII promoted the production of soluble inflammatory mediators such as IL6 and IDO1, which resulted in a non-cell-autonomous immune-suppressive tumor microenvironment that is characterized by increased LAG3+ CD8 and CD4 T cells (Fig. 6H). The gene discussed is IDO1; the disease is neoplasm.